Clinical Trials Logo

Filter by:
NCT ID: NCT01035619 Withdrawn - Onchocerciasis Clinical Trials

Pediatric Pharmacokinetics And Safety Study Of Moxidectin

Start date: April 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to measure the amount of moxidectin in subjects' blood and to measure safety. This study will enroll 36 children aged 4 to 11 years (>=12 kg) with or without Onchocerca volvulus (O volvulus) infection. O volvulus is the nematode, or roundworm, that causes Onchocerciasis, also known as river blindness. Each subject will receive a single dose of 4 mg moxidectin (orally administered) and will be followed inpatient from screening through day 13 and as outpatients through month 6. The study will take place at a single research center.

NCT ID: NCT01125735 Withdrawn - Clinical trials for Chronic Nonhealing Wounds

MIST Therapy's Effectiveness in Wound Bed Preparation and Role of Bacterial Biofilm in Chronic, Non-healing Wounds

Celleration
Start date: April 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of MIST Therapy in combination with standard of care (SOC) compared to SOC alone on reducing the bacteria in your wound and preparing the wound bed for surgical closure in patients that have chronic, non-healing wounds. The MIST Therapy System delivers therapeutic ultrasound to the wound bed without direct contact. Saline solution is converted into fine particles and released towards the wound by sound pressure waves to remove dead or damaged tissue. The MIST Therapy System is currently the only FDA cleared non-contact ultrasound device to promote wound healing. Standard of care procedures include surgical debridement of the wound in the operating room to remove all infected, dead tissue and bone. This research is being done because the investigators do not know which of these commonly-used treatments is better, and because the investigators would like to evaluate the bacteria that is present in the wound.

NCT ID: NCT01141296 Withdrawn - Clinical trials for Primary Biliary Cirrhosis

Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

Start date: April 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if the combination of ursodeoxycholic acid (UDCA) and fenofibrate is more effective than UDCA alone in the treatment of primary biliary cirrhosis.

NCT ID: NCT01256346 Withdrawn - Prematurity Clinical Trials

Electrocardiography Versus Pulse Oximetry for Newborn Heart Rate Determination

Start date: April 2011
Phase: N/A
Study type: Observational

The goal of this study is to compare the time required for accurate heart rate measurement of the preterm newborn when using pulse oximetry versus electrocardiography leads.

NCT ID: NCT01257126 Withdrawn - Clinical trials for Upper Respiratory Tract Infections

Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract Infection

Start date: April 2011
Phase: Phase 4
Study type: Interventional

This is a local, phase IV, open-label, randomized, head to head study of children aged 3 to 7 years. The objective of the study is to compare the efficacy of a single dose of both diclofenac potassium and nimesulide in the reduction of fever and pain secondary to upper respiratory tract infection.

NCT ID: NCT01260844 Withdrawn - Clinical trials for Moderate to Severe Plaque Psoriasis

Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

Start date: April 2011
Phase: Phase 1
Study type: Interventional

Phase 1, drug-drug interaction study to evaluate the effects of Briakinumab on hte pharmacokinetics of single doses of CYP substrate in subjects with moderate to severe psoriasis.

NCT ID: NCT01285505 Withdrawn - Healthy Clinical Trials

Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation

Start date: April 2011
Phase: Phase 1
Study type: Interventional

This study tests the hypothesis that the bioavailability of alprazolam from a new sublingual formulation is the same as that from an existing sublingual formulation.

NCT ID: NCT01293149 Withdrawn - Clinical trials for Other Reconstructive Surgery

Clonidine in Femoral Nerve Block Surgery in Children

Start date: April 2011
Phase: Phase 2
Study type: Interventional

Knee arthroscopy is a common surgical procedure in pediatrics in which the knee joint is visualized through a small camera to help diagnose and treat knee problems. This procedure is commonly accomplished with the use of general anesthesia. Regional anesthesia is commonly completed with a single injection of local anesthetic around the femoral nerve to provide pain relief for several hours following knee arthroscopy. The intent of this study is to examine the effects of clonidine in addition to local anesthetics for femoral nerve blockade in providing children and adolescents post-operative analgesia. The investigators hypothesize the addition of low dose clonidine (1 mcg/kg) provides an additional 4 hours of post operative analgesia following arthroscopic knee surgery and reduces post-operative opiate requirement.

NCT ID: NCT01295970 Withdrawn - Clinical trials for Patients With a Single Brain Metastasis

Surgery Versus Radiosurgery for the Treatment of Single Brain Metastases

Start date: April 2011
Phase: N/A
Study type: Interventional

Usually the treatment of a single brain metastasis is surgery or Stereotactic Radiosurgery (SRS). Surgery involves resection of the brain tumor by means of an operation, whereas SRS is treatment consisting of highly focused radiation doses to the tumor. These two treatment modalities are both widely used, well established, and proven to improve survival, but so far, no study has been done to directly compare the efficacy of one over the other. Neither treatment in itself is considered to be experimental and both have been shown to provide benefits to patients with metastatic brain tumors. The aim of this study is to determine which two modalities are better for local control and improving quality of life. Patients who consent to this study will be randomized to either receive surgery or Radiosurgery in the treatment of single brain metastases. The study seeks to recruit 12 patient to each group. Patients will be in this study for up to five years from the time of the treatment finished. This will include follow-up visits at 4 weeks after the procedure and then every 3 months after the procedure up to 5 years.

NCT ID: NCT01297426 Withdrawn - Obesity Clinical Trials

Leptin Signaling in Lean and Obese Humans

Leptin signali
Start date: April 2011
Phase: N/A
Study type: Observational

Obesity does not respond to high circulating levels of the hormone leptin. This study is aiming at finding out why this happens and open new avenues for treatment of obesity.